national organ donation committee, 28.01014 objectives –welcome new members / attendees...

26
National Organ Donation Committee, 28.01014 • Objectives Welcome new members / attendees Feedback on the proposed revisions to the pregnancy policy Review the educational activities of the Committee Contribute to the understanding of the current increases in deceased donation Advise ODT of the likely impact of any reduction in investment on donation-related activities Report on work in regional collaboratives Consider the future working arrangements of NODC

Upload: ashley-booker

Post on 18-Dec-2015

213 views

Category:

Documents


0 download

TRANSCRIPT

National Organ Donation Committee, 28.01014

• Objectives– Welcome new members / attendees– Feedback on the proposed revisions to the pregnancy

policy– Review the educational activities of the Committee– Contribute to the understanding of the current

increases in deceased donation– Advise ODT of the likely impact of any reduction in

investment on donation-related activities– Report on work in regional collaboratives– Consider the future working arrangements of NODC

Matters arising

a) Extended DCD project (Roberto Cacciola)

b) St John’s Award (Dale Gardiner)

c) Clinical microsite (John Richardson / James Neuberger)

c) Pregnancy and Organ Donation (Huw Twamley / Liz Waite)

d) Regional on-call nurses (Sri Nagaiyan)

e) Club 32 (Dale Gardiner)

Pregnancy and organ donation MPD

Summary of Significant Changes

2.1 Where a pregnancy is suspected a ß-HCG blood test must be performed to confirm pregnancy. 2.3 Age criteria within this policy 13 – 55 years of age2.4 In relation to deceased patients, to undertake a pregnancy test without the consent/authorisation of the patient’s family/husband/partner is permissable, if the test is needed as part of the donation process.If pregnancy testing is not possible, donation should only proceed with the agreement of the family and also the retrieval surgeon.3.1 Female patients should not be tested for pregnancy until the family have given consent/authorisation for organ and/or tissue donation or if the wishes of the patient to donate were clearly stated ( such as joining the organ donor register)3.4 If the blood test is positive, pregnancy should be confirmed by the relevant specialist clinician or alternative cause for the positive test sought e.g. Choriocarcinoma ( which would be a contra-indication to organ or tissue donation).

Current UK donor and transplant activity

Current year(01.04.13 – 12.01.14)

Previous year(01.04.12 – 12.01.13)

% ChangePrevious full financial year(2012/2013)

ORGAN DONORS

Donors after brain death 611 532 14.8 705

Donors after circulatory death

438 387 13.2 507

Total deceased donors 1049 919 14.1 1212

Deceased donors (DD) transplants

Kidney 1543 1320 16.9 1750

Pancreas 20 29 -3.1 37

Kidney/pancreas 151 123 22.8 166

Pancreas islets 27 27 0 30

Heart 155 106 46.2 142

Lung(s) 167 145 15.2 188

Liver 678 591 14.7 775

Total DD transplants 2711 2363 17.3 3113

Number of donors, April 1st to January 12th

2003/4 – 2013/4

Proportion of DBD and DCD donors, up to12.01.14

Key DBD rates

Number of patients at each stage of pathway

Age proportions of actual donors

Age distributions along the DBD organ donation pathway (1)

Age distributions along the DBD organ donation pathway (2)

Key DBD rates for 18 to 34 year olds

Education and Training

NODC Terms of ReferenceTo lead the design and delivery of training and development opportunities for clinical staff involved in the care of potential deceased organ donors, including (but not limited to)

– refresher courses for CLODs and Donation Committee Chairs

– the National Donation Congress,

– relevant areas of the NHSBT organ donation microsite and organ donation toolkit

– the Map of Medicine organ donation pathways

Education and Training

a) Evaluation of doctors/nurses attitudes, knowledge & training towards organ and tissue donation (Tim Collins)

b) National Donation and Transplantation Congress (Paul Murphy / Olive McGowan)

c) Training course for ICM trainees (Dale Gardiner)

d) Role of NODC in education and training (all)

Updates

a) ACCORD (Paul Murphy / Sally Johnson)

b) DePPart (Dale Gardiner)

c) NICE Guidance (Gus Vincent)

d) Scout Pilot (Gerlinde Mandersloot)

e) UK DEC (Dale Gardiner / Paul Murphy)

i. Heparin in DCD

ii. Draft Guidance in DBD

iii. Workshop on future workstreams (7th March, London)

f) TOT2020 (Sally Johnson / James Neuberger)

i. Workforce review (Anthony Clarkson for Ella Poppitt)

g) Substitution Study (Alex Manara / James Neuberger)

h) Statistics Group (Jo Allen)

ACCORD

• EU funded programme• UK leading workstream 5

– Promoting cooperation between ICUs and donor transplant coordination

– Impact of end of life care on organ donation• 17 participating member states

• 66 participating hospitals

• WS5 design– Audit of ≥ 20 consecutive patients dying of brain injury in 6

month study period (1670 completed patient Qs) – Change methodology training and action plans– Re-evaluation

ACCORD: country questionnaire

•DCD programme

•Legal definition of death

•Guidance for

–diagnosis of brain death

–care of potential donors

–ethical guidance

–withdrawal of life sustaining treatments

–donor identification and referral

–family approach

•Training

•National and / or regional OPOs

•Regulatory authority

Donor rate by number of positive national indicators for organ donation

Portugal

GermanyHungary

Slovenia

Croatia

Lithuania

Rep. Ireland

Greece

Italy

Netherlands

Spain

LatviaEstonia

France

UK

0

5

10

15

20

25

30

35

40

5 6 7 8 9 10 11

Number of positive indicators

Do

no

r ra

te p

mp

(20

11)

No DCD programme

DCD programme

Care paradigms of study patients

0% 20% 40% 60% 80% 100%

CROATIA (66)

ESTONIA (94)

FRANCE (87)

GERMANY (40)

GREECE (28)

HUNGARY (56)

IRELAND (31)

ITALY (75)

LATVIA (12)

LITHUANIA (81)

PORTUGAL (43)

SLOVENIA (18)

SPAIN (413)

NETHERLANDS (95)

UK (531)

ALL MS (1670)

A: Full active treatment on CCU until the diagnosis of BD

B: Full active treatment until unexpected cardiac arrest from which the patient could not be resuscitated

C: Admitted to CCU to incorporate organ donation into end-of-life care

D: Full active treatment on CCU until the decision of withdrawal or limiting life sustaining therapy was made, withan expected final cardiac arrestE: Not admitted, or admitted to CCU but subsequently discharged

proceeding DCD, n = 35

0

50

100

150

200

250

300

1 7 13 19 25 31 37 43 49 55 61 67 73 79 85 91 97 103 109 115

time after withdrawal (min)

sy

sto

lic

BP

(m

mH

g)

Heparin and DCD

Time from SBP< 50 to asystole (min):

median 5

minimum 1

maximum 26

Heparin and DCD

non proceeding DCD, n = 28

0

50

100

150

200

250

300

1 9 17 25 33 41 49 57 65 73 81 89 97 105 113 121 129 137 145 153 161 169 177

time after treatment withdrawal (min)

syst

oli

c B

P (

mm

Hg

)

Regional Collaboratives

a) Vision for regional collaboratives (Dale Gardiner)

b) Reports from regional collaboratives, outcomes from this

year’s work, priorities for 2014/15 and update on the

promotion of the family approach material (Regional

Managers / Regional CLODs)

c) Overview (all)

National Donation Committee – Terms of Reference

• Service development

– To act as a source of advice and assistance to NHSBT in the development and implementation of strategies to increase organ, corneal and tissue donation

– To provide a forum for identifying and spreading best practice across the UK

– To assist NHSBT to improve and optimise all aspects of donation to enable more transplants to take place,

• Representative and performance

– To represent, lead and support the UK wide network of Donation Committees and Regional Collaboratives ensuring that regional issues are raised and shared at a national level

• Education and training

– To lead the design and delivery of training and development opportunities for clinical staff involved in the care of potential deceased organ donors

• Consultative

– To promote effective dialogue and collaboration between relevant professional groups and the Colleges and Societies that may represent them,

• Research

– To sponsor and support research, development and audit relevant to deceased donation, including (but not limited to) the analysis and future development of the Potential Donor Audit

• To commission a small number of working subgroups that will deliver the key objectives of the committee

National Donation Committee – membership

National Clinical Lead for Organ DonationDeputy National Clinical Lead for Organ DonationNational Clinical Lead for Donor OptimisationNational Clinical Lead for Governance

Associate Medical Director for Organ Donation and Transplantation

Regional Clinical Leads – Scotland– Midlands – Yorkshire and Humber– South East Coast – East of England – North West – London – Northern – South Central– South East– South West– South Wales

Donation Committee Chair

Director, Organ Donation and TransplantationAssistant Director for Operations, Organ DonationHead of Service DevelopmentHead of Service DeliveryLead Nurse for Health Informatics

Regional Managers for Organ Donation– London and Northern Ireland– South East and Eastern England– South West and South Wales– Northern and Scotland– Midlands and South Central– North West and Northern

Statistics and Clinical Studies, NHSBT

Professional representatives – Royal College of Anaesthetists– Faculty of Intensive Care Medicine – Intensive Care Society– British Association of Critical Care Nursing– College of Emergency Medicine– Royal College of Child Health and Paediatrics /

Paediatric Intensive Care Society – British Transplantation Society– Society of British Neurological Surgeons

National Donation Committee - contributions

• Donor identification and referral policy

• Family approach Best Practice Guide and DVD

• National Donation Congress 2012 and National Donation and Transplantation Congress 2013

• Review of Map of Medicine pathways

• National pilot of simulation training for ICM trainees

• St John Award

• Scout pilot

• Club 32

• Taking Organ Transplantation to 2020

• Development of the clinical microsite

• Regional Organ Donation Roadshows 2013

• DBD / DCD substitution study

National Donation Committee – proposals

• Option 1 – streamlined status quo

Accept the reality of the landscape for deceased donation in the UK, but reconsider the need for both the Regional Manager and Regional Clinical Lead to attend all meetings.

• Option 2 – disentangle the various responsibilities of the National Donation Committee and support each separately

Limit the National Organ Donation Committee to the original advisory and consultative roles of the Donation Advisory Group, reducing frequency of meetings accordingly. Fulfill other responsibilities of the National Donation Committee through separately supported groups and pathways

• Option 3 – hybrid option

Reduce frequency and objectives of full meetings of the National Donation Committee. Formally establish subgroups with the following responsibilities:

–Consultative

–Education and training

–Research, statistics and audit

–Service development

–Performance